TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
How It Works
Start Here
Spark Generator
Stock Deep Dives
AI Analyst
Agentic Chat
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Spark Charts
AI Technical Analysis
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
Members AreaMembers Area
Log inCreate Account
← All Commentary
▌Opinion·June 26, 2026

Trip.com’s post-earnings plunge says the China travel recovery trade is officially over

Trip.com’s quarter was good enough for yesterday’s story, not tomorrow’s multiple. When management follows 17% Q1 revenue growth with just 3% to 8% Q2 guidance, the market is right to kill the China travel recovery premium.

OpinionBear CaseTCOM
By TickerSpark·June 26, 2026·4 min read
Trip.com’s post-earnings plunge says the China travel recovery trade is officially over
▌The Data Behind the Take
Trip.com Group LimitedTCOM
Full data →
TickerSpark Score
82
out of 100
Q2 Guidance
3%–8% YoY
The number we're watching
Score Breakdown
Valuation97
Profitability100
Growth

§ Product

  • How It Works
  • Spark Generator
  • AI Analyst
  • Plans

§ Research

  • Main Feed
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

90
Health92
Momentum30

Trip.com’s post-earnings break looks less like a buying opportunity and more like a regime change. The key issue is simple: a stock that had been treated like a recovery compounder just guided Q2 revenue growth down to 3% to 8% after posting 17% growth in Q1, and that kind of deceleration does not support a premium narrative. The market’s reaction makes sense because this was not a demand collapse hidden in the quarter; it was management telling investors the slowdown is arriving now. Once that happens, valuation stops being the bull case and starts being a warning that expectations were too high.

The cleanest evidence is the gap between what Trip.com reported and what it guided. Q1 2026 revenue rose 17% year over year to RMB16.2 billion, which on its own would have looked solid, yet the stock still got hit because management told investors Q2 growth would slow to just 3% to 8% and said that would have a corresponding impact on margins and bottom-line results. That is the market admitting the recovery trade is over: not because the last quarter was bad, but because the next one looks ordinary.

Price action confirms this is more than a one-day tantrum. TCOM is down 45.6% year to date, lagging the Consumer Cyclical sector by 41.3 percentage points, and the technical backdrop is outright broken. The shares sit below the 20-day, 50-day, and 200-day moving averages, with the 200-day all the way up at 61.48 versus a latest close of 40.49, while the RSI has sunk to 27.39 and on-balance volume is trending in distribution. Oversold does not mean cheap in motion; it often means institutions are still exiting.

That is why the low multiple is not the rescue argument bulls want it to be. TCOM trades at 5.51 times earnings and 3.89 times EV/EBITDA, with a TickerSpark Score of 82 powered by a 97 Valuation score and 100 Profitability score, but the market is looking straight through those numbers because momentum has collapsed to 30. A stock can be statistically cheap and still deserve to stay cheap when growth is decelerating, estimates are being cut, and the company is still dealing with competition-law and consumer-protection inquiries. The downgrade cycle is already underway, with Macquarie moving to Neutral and multiple firms trimming targets after the print.

There is a real bull case here, and it is not hard to state. Trip.com remains highly profitable, with an 80.3% gross margin, 24.9% operating margin, and 48.7% net margin, while the broader growth profile still looks strong on the surface with revenue up 13.9% and EPS up 88.6% year over year. Management also highlighted international gross bookings growth of about 65% and inbound travel bookings up about 90%, which tells you the franchise itself is not broken.

That is exactly why this selloff matters so much. If a company with those margins, that international momentum, and a 7-for-8 earnings beat history still gets punished this hard after earnings, the market is sending a message that the old multiple framework no longer applies. Even compared with EXPE, which trades at 14.22 times earnings on 7.6% revenue growth, TCOM looks optically cheaper, but the market is discounting China exposure, regulatory noise, and a much sharper near-term slowdown than the trailing numbers suggest. The bulls have facts; the bears have the timeline, and the timeline wins.

That leaves TCOM looking like a stock to avoid rather than a dip to chase. We would treat the June 24 earnings reset as the line in the sand: until the company proves that 3% to 8% Q2 growth was a temporary air pocket instead of the new normal, the path of least resistance stays lower. Cheap stocks with broken momentum can stay cheap for a long time, especially when the market has stopped believing the story.

What would change our mind is not another argument about valuation but evidence that growth is reaccelerating and regulatory pressure is fading. Short of that, the more disciplined move is to respect the trend, not fight it. For retail investors, this is the kind of name that can look irresistibly inexpensive on a screen and still keep destroying capital if the narrative reset is only in its first inning.

Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
Read our full research report on TCOM →
▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌The Full Report

Want the full picture on TCOM?

The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

Read the TCOM report →Get Full Access →
▌The Full Report

Get the full TCOM research report

  • Analyst-grade deep dive
  • Charts, valuation, grades
  • Buy/sell price targets
Read the TCOM report →
▌For Active Investors

Smarter research, on every ticker

  • Daily market intelligence
  • On-demand stock analysis
  • AI analyst chat
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌More commentary

More to read

All articles
Trip.com Group (TCOM): International Growth Meets Cash-Rich Value
TCOM

Trip.com Group (TCOM): International Growth Meets Cash-Rich Value

Trip.com Group combines fast international travel growth with strong profitability and a net cash balance. The stock looks attractive despite slower near-term guidance and regulatory risk.

Jun 25·23 min
Trip.com Group Limited (TCOM) falls 11% on earnings miss
TCOM

Trip.com Group Limited (TCOM) falls 11% on earnings miss

Trip.com Group Limited (TCOM) falls after-hours as investors react to a small earnings miss and much softer Q2 revenue growth guidance. The travel platform still posted solid revenue and strong international bookings, but the market is repricing the stock for slower near-term growth and margin pressure.

Jun 25·6 min
newcleo's De-SPAC: What Investors Need to Know

newcleo's De-SPAC: What Investors Need to Know

newcleo, the advanced nuclear company developing lead-cooled fast reactors and MOX fuel, is going public via a merger with NewHold Investment Corp. III (Nasdaq: NHIC). The deal values newcleo at about $2.4 billion pre-money and could bring in roughly $429 million before redemptions, but the setup still carries heavy execution, regulatory, and dilution risk.

Jul 4·6 min